[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

SE437522B - (6r,7r)-7-/2-(2-amino-4-tiazolyl)-2-(z-metoxiimino)-acetamido/-3-(substituerad tiometyl)-cefalosporinsyra samt legre alkanoylalkyl estar/etrar derav - Google Patents

(6r,7r)-7-/2-(2-amino-4-tiazolyl)-2-(z-metoxiimino)-acetamido/-3-(substituerad tiometyl)-cefalosporinsyra samt legre alkanoylalkyl estar/etrar derav

Info

Publication number
SE437522B
SE437522B SE7904682A SE7904682A SE437522B SE 437522 B SE437522 B SE 437522B SE 7904682 A SE7904682 A SE 7904682A SE 7904682 A SE7904682 A SE 7904682A SE 437522 B SE437522 B SE 437522B
Authority
SE
Sweden
Prior art keywords
salts
methyl
oxo
formula
esters
Prior art date
Application number
SE7904682A
Other languages
English (en)
Swedish (sv)
Other versions
SE7904682L (sv
Inventor
M Montavon
R Reiner
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH588278A external-priority patent/CH641468A5/de
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of SE7904682L publication Critical patent/SE7904682L/xx
Publication of SE437522B publication Critical patent/SE437522B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36—Methylene radicals, substituted by sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fats And Perfumes (AREA)
  • Mutual Connection Of Rods And Tubes (AREA)
  • Reinforcement Elements For Buildings (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
SE7904682A 1978-05-30 1979-05-29 (6r,7r)-7-/2-(2-amino-4-tiazolyl)-2-(z-metoxiimino)-acetamido/-3-(substituerad tiometyl)-cefalosporinsyra samt legre alkanoylalkyl estar/etrar derav SE437522B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH588278A CH641468A5 (de) 1978-05-30 1978-05-30 Cephemderivate.
CH224879 1979-03-08

Publications (2)

Publication Number Publication Date
SE7904682L SE7904682L (sv) 1979-12-01
SE437522B true SE437522B (sv) 1985-03-04

Family

ID=25689901

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7904682A SE437522B (sv) 1978-05-30 1979-05-29 (6r,7r)-7-/2-(2-amino-4-tiazolyl)-2-(z-metoxiimino)-acetamido/-3-(substituerad tiometyl)-cefalosporinsyra samt legre alkanoylalkyl estar/etrar derav

Country Status (40)

Country Link
EP (2) EP0005830B1 (no)
JP (2) JPS54157596A (no)
AT (3) AT367764B (no)
BG (1) BG50163A3 (no)
BR (1) BR7903368A (no)
CA (1) CA1141373A (no)
CS (1) CS219254B2 (no)
CU (1) CU35088A (no)
CY (1) CY1182A (no)
DD (1) DD143911A5 (no)
DE (4) DE2922036C2 (no)
DK (1) DK149282C (no)
EG (1) EG14153A (no)
ES (2) ES480990A1 (no)
FI (1) FI65434C (no)
FR (2) FR2427337A1 (no)
GB (2) GB2022090B (no)
GR (1) GR72242B (no)
HK (1) HK31383A (no)
HU (1) HU183089B (no)
IE (1) IE49047B1 (no)
IL (1) IL57392A (no)
IS (1) IS1203B6 (no)
IT (1) IT1121517B (no)
KE (1) KE3268A (no)
LU (1) LU81325A1 (no)
MC (1) MC1259A1 (no)
MT (1) MTP845B (no)
MY (1) MY8400127A (no)
NL (1) NL7904083A (no)
NO (1) NO159797C (no)
NZ (1) NZ190532A (no)
OA (1) OA06263A (no)
PH (1) PH15148A (no)
PL (1) PL122458B1 (no)
PT (1) PT69698A (no)
RO (1) RO77560A (no)
SE (1) SE437522B (no)
SG (1) SG10483G (no)
YU (3) YU42485B (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI67385C (fi) * 1979-11-21 1985-03-11 Hoffmann La Roche Foerfarande foer framstaellning av (6r 7r)-7-(2-(2-amino-4-tiazolyl)-2-(z-metoxiimino)acetamido)-3-cefem-4-karboxylsyraderivat
US4349672A (en) * 1979-11-29 1982-09-14 Hoffmann-La Roche Inc. Cephalosporin derivatives
AU536771B2 (en) * 1980-03-25 1984-05-24 F. Hoffmann-La Roche Ag Cephalosporin derivatives
CA1154009A (en) * 1980-03-25 1983-09-20 Roland Reiner Cephalosporin derivatives
GR75711B (no) * 1980-06-30 1984-08-02 Sanofi Sa
US4308267A (en) 1980-07-03 1981-12-29 Smithkline Corporation 7-[2-Alkoxyimino-2-(amino-thiazole)acetamido]-3-[1-(sulfaminoalkly)tetrazolthiomethyl]cephalosporins
DK379581A (da) * 1980-10-06 1982-04-07 Hoffmann La Roche Fremgangsmaade til fremstilling af acylderivater
FR2494278A1 (fr) * 1980-11-20 1982-05-21 Rhone Poulenc Ind Nouveaux derives de la cephalosporine, leurs preparations et les medicaments qui les contiennent
EP0058250A3 (de) * 1981-02-17 1983-08-17 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Cephalosporinderivate, deren Herstellung und entsprechende pharmazeutische Präparate
EP0185220A3 (de) * 1984-12-19 1987-09-02 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Zwischenprodukte zur Herstellung von Cephalosporinen
EP0238060B1 (en) 1986-03-19 1992-01-08 Banyu Pharmaceutical Co., Ltd. Cephalosporin derivatives, processes for their preparation and antibacterial agents
RU2021274C1 (ru) 1991-05-17 1994-10-15 Польска Акадэмия Наук Институт Хэмии Органичнэй Способ получения аминотиазолильных производных цефалоспорина
KR950014571B1 (ko) * 1991-11-18 1995-12-08 제일제당주식회사 세펨 유도체의 제조방법
AT398764B (de) * 1992-01-28 1995-01-25 Lek Tovarna Farmacevtskih Verfahren zur herstellung von ceftriaxondinatrium-salzhemiheptahydrat
AT399877B (de) * 1992-02-20 1995-08-25 Biochemie Gmbh Neues verfahren zur herstellung von ceftriaxon
KR100197788B1 (ko) * 1995-06-30 1999-06-15 김충환 세펨 유도체의 제조방법
DE102011117421A1 (de) 2011-11-02 2013-05-02 Hans-Peter Gabel Pharmazeutische Zusammensetzung zur Behandlung von Borreliose
RU2504548C1 (ru) * 2012-09-28 2014-01-20 Федеральное Государственное Автономное Образовательное Учреждение Высшего Профессионального Образования "Сибирский Федеральный Университет" (Сфу) ПРОИЗВОДНОЕ β-ЛАКТАМНОГО АНТИБИОТИКА ЦЕФТРИАКСОНА

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH609989A5 (en) * 1974-06-21 1979-03-30 Hoffmann La Roche Process for the preparation of acyl derivatives
CA1100129A (en) * 1974-08-02 1981-04-28 William H.W. Lunn Cephalosporin compounds
FR2345153A1 (fr) * 1976-03-25 1977-10-21 Roussel Uclaf Nouvelles alcoyloximes derivees de l'acide 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments
DK162391C (da) 1976-04-12 1992-03-09 Fujisawa Pharmaceutical Co Analogifremgangsmaade til fremstilling af syn-isomerer af 3,7-disubstituerede 3-cephem-4-carboxylsyreforbindelser
GR63088B (en) * 1976-04-14 1979-08-09 Takeda Chemical Industries Ltd Preparation process of novel cephalosporins
JPS5329936A (en) * 1976-08-31 1978-03-20 Takeda Chem Ind Ltd Antibiotic composition
GB1599232A (en) * 1977-06-03 1981-09-30 Hoffmann La Roche 7-(2-oximinoacetamido)-cephalosporin derivatives
US4200745A (en) * 1977-12-20 1980-04-29 Eli Lilly And Company 7[2-(2-Aminothiazol-4-yl)-2-alkoxyimino]acetamido 3[4-alkyl-5-oxo-6-hydroxy-3,4 dihydro 1,2,4-triazin 3-yl]thio methyl cephalosporins

Also Published As

Publication number Publication date
EP0005830B1 (de) 1982-09-22
NO791776L (no) 1979-12-03
DK222679A (da) 1979-12-01
ATE1586T1 (de) 1982-10-15
PT69698A (en) 1979-06-01
GB2099418A (en) 1982-12-08
EP0045525A2 (de) 1982-02-10
ES488687A0 (es) 1980-12-16
KE3268A (en) 1983-05-13
DE2966946D1 (en) 1984-05-30
FR2509312A1 (fr) 1983-01-14
GB2022090A (en) 1979-12-12
ATE7229T1 (de) 1984-05-15
CU35088A (en) 1982-08-24
AU524230B2 (en) 1982-09-09
YU123379A (en) 1983-04-30
SE7904682L (sv) 1979-12-01
YU45257B (en) 1992-05-28
IT1121517B (it) 1986-04-02
JPS613355B2 (no) 1986-01-31
YU74585A (en) 1987-12-31
EG14153A (en) 1983-03-31
IL57392A0 (en) 1979-09-30
DK149282C (da) 1986-09-01
MY8400127A (en) 1984-12-31
IT7923049A0 (it) 1979-05-28
NO159797B (no) 1988-10-31
IE791041L (en) 1979-11-30
BR7903368A (pt) 1979-12-11
IS2490A7 (is) 1979-12-01
OA06263A (fr) 1981-06-30
NZ190532A (en) 1983-03-15
AT367764B (de) 1982-07-26
NO159797C (no) 1989-02-08
FI791703A (fi) 1979-12-01
LU81325A1 (de) 1980-12-16
FR2427337A1 (fr) 1979-12-28
GB2022090B (en) 1982-12-15
IL57392A (en) 1982-05-31
CY1182A (en) 1983-10-07
AU4736679A (en) 1979-12-06
FR2509312B1 (no) 1984-06-29
DE2954159C2 (de) 1983-10-06
ES8101606A1 (es) 1980-12-16
PL215972A1 (no) 1980-02-11
DD143911A5 (de) 1980-09-17
NL7904083A (nl) 1979-12-04
CA1141373A (en) 1983-02-15
DE2922036A1 (de) 1979-12-06
MC1259A1 (fr) 1980-01-14
EP0045525A3 (en) 1982-02-17
YU45256B (en) 1992-05-28
YU74485A (en) 1987-12-31
EP0045525B1 (de) 1984-04-25
FI65434B (fi) 1984-01-31
JPS54157596A (en) 1979-12-12
DE2963720D1 (en) 1982-11-04
YU42485B (en) 1988-10-31
RO77560A (ro) 1982-04-12
GB2099418B (en) 1983-06-02
GR72242B (no) 1983-10-04
PH15148A (en) 1982-08-24
DK149282B (da) 1986-04-21
CS219254B2 (en) 1983-03-25
SG10483G (en) 1983-12-16
BG50163A3 (en) 1992-05-15
IE49047B1 (en) 1985-07-24
HK31383A (en) 1983-09-02
PL122458B1 (en) 1982-07-31
DE2922036C2 (de) 1983-02-17
JPS613795B2 (no) 1986-02-04
ES480990A1 (es) 1980-08-16
EP0005830A1 (de) 1979-12-12
JPS6016994A (ja) 1985-01-28
MTP845B (en) 1980-07-21
HU183089B (en) 1984-04-28
IS1203B6 (is) 1986-03-24
ATA390479A (de) 1981-12-15
FI65434C (fi) 1984-05-10

Similar Documents

Publication Publication Date Title
SE437522B (sv) (6r,7r)-7-/2-(2-amino-4-tiazolyl)-2-(z-metoxiimino)-acetamido/-3-(substituerad tiometyl)-cefalosporinsyra samt legre alkanoylalkyl estar/etrar derav
US4327210A (en) Thiazolylacelamide cephalosporins
CS209878B2 (en) Method of making the new alcyloxime derivatives of the 7-/2-(2-amino-4-thiazolyl)acetamido/cephalosporan acid
KR830000835B1 (ko) 세팔로스포린 항생제의 제조방법
HU182960B (en) Process for preparing cefem-carboxylic acid derivatives with antibiotic activity
CA1225390A (en) 3-bicyclicpyridinium-methyl cephalosporins
US5202315A (en) Cephalosporin compounds
US4971962A (en) Cephalosporin compounds
CS204957B2 (en) Method of producing novel 7-2-/4-thiazolyl/-2-iminoacetamido-3-/4-alkyl-5-oxo-6-hydroxy-4,5-dihydro-1,2,4-triazin-3-ylthio/methyl-3-cephemderivatives
US4757065A (en) Cephalosporins
SE452324B (sv) 7-beta-/alfa-syn-metoxiimino-alfa(2-aminotiazol-4-yl)-acetamido/-3-/(1,2,3-tiadiazol-5-yltio) metyl/-3-cefem-4-karboxylsyra samt derivat derav och farmaceutiska kompositioner derav
US4349672A (en) Cephalosporin derivatives
CA1114808A (en) Derivatives of 7-¬substituted oxyiminoacetamido| cephalosporins
CA1151641A (en) Cephalosporin esters and ethers
US4482551A (en) Cephalosporin derivatives
CA1177823A (en) Cephalosporin derivatives
EP0492277A2 (en) Cephalosporin derivatives
US4497811A (en) 1-Oxadethiacephalosporin compound and antibacterial agent containing the _same
EP0098615B1 (en) 1-oxadethiacephalosporin compound and antibacterial agent containing the same
US4379924A (en) Cephalosporin derivatives
FI67084B (fi) Vid framstaellning av terapeutiskt vaerdefulla cefalosporiner anvaendbara 7-(2-(2-(skyddad-amino)-4-tiazolyl)-2-metoxiiminoacetamido)cefalosporinderivat
KR0143534B1 (ko) 신규 세팔로스포린계 화합물과 그의 제조방법
US4409387A (en) Cephalosporin derivatives
US4173703A (en) Preparation of carbamates
SI7911233A8 (sl) Postopek za pripravo derivatov cefalosporina